查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1844153

疼痛管理設備市場（按設備類型、應用程式、分銷管道、最終用戶和購買方式分類）—2025-2032年全球預測

Pain Management Devices Market by Device Type, Application, Distribution Channel, End User, Mode of Purchase - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，疼痛管理設備市場規模將達到 73.2 億美元，複合年成長率為 9.06%。

主要市場統計數據
基準年 2024 36.5億美元
預計年份：2025年 39.7億美元
預測年份：2032年 73.2億美元
複合年成長率 (%) 9.06%

清晰的策略方向，為塑造現代疼痛管理器材策略的不斷變化的臨床、商業和法規環境奠定基礎。

本執行摘要首先為複雜且快速發展的疼痛管理設備領域提供循證指導，闡明了報告的目標及其為臨床、商業和政策相關人員帶來的價值。

引言部分重點闡述並分析了影響產品開發和應用的各種因素，包括向非鴉片類藥物治療策略的轉變、門診和居家照護模式的興起，以及數位健康功能與設備平台的日益融合。這些動態正在重塑臨床管道，並影響醫生、醫院管理者和支付方的決策標準。鑑於臨床偏好和以患者為中心的護理趨勢的變化，設備製造商和服務供應商必須重新審視產品系列、市場推廣模式和合作夥伴關係。

本節概述了報告的分析框架和整合的證據類型，重點闡述了監管考慮、報銷壓力、供應鏈韌性和技術融合如何影響後續的分析結果。引言圍繞著安全性、有效性、易用性和整合性提出關鍵問題，為讀者提供了一個實用的視角，以便他們解讀後續章節，並將研究結果應用於產品策略、市場推廣計畫和投資評估。

臨床偏好的改變、醫療服務的分散化、數位化整合以及監管期望的演變，正在重新定義疼痛管理設備的產品和商業策略。

疼痛管理設備領域正在經歷多項變革時期，這些變革正在改變臨床工作流程、產品生命週期和商業性重點。

首先，隨著臨床醫生尋求持久有效的非藥物治療方法以減少對全身性止痛藥物的依賴，神經調控和微創治療已成為治療領域的一大趨勢。這一趨勢推動了對電刺激、射頻技術和磁療的研究，這些技術能夠靶向特定的疼痛通路，同時保持患者的活動能力並減少長期用藥。其次，醫療服務模式正向活性化發展。專為居家照護環境設計的安全有效設備正日益受到重視，因為它們有助於縮短住院時間，並符合病患對便利性和隱私性的偏好。第三，從遠端監測和設備遠端檢測到基於應用程式的治療劑量調整和依從性工具，數位化增強技術正成為影響臨床療效和醫療保險報銷的關鍵因素。

同時，監管管道和證據要求也在不斷演變，更加強調實際應用效果和上市後籌資策略對於產品持續供應至關重要，而醫療器材製造商與服務供應商之間的策略夥伴關係則正在加快產品從研發到臨床應用的進程。面對這些變化，企業必須採取整合策略，將臨床檢驗、監管規劃和商業執行有機結合起來，以保持競爭力並與時俱進。

2025年累積關稅以及由此導致的供應鏈和採購調整，已經重塑了成本結構、供應商策略和產品上市時間表。

2025 年實施的累積關稅加劇了整個醫療技術供應鏈的成本壓力和採購複雜性，給製造商和下游供應商帶來了營運壓力。

對關鍵進口零件和組件徵收的關稅增加了依賴國際採購電子模組、精密元件和特殊聚合物的設備製造商的到岸成本。為此，許多公司立即採取了成本緩解措施，例如重新談判供應商合約、增加庫存緩衝以及加快對受影響較小國家的替代供應商進行資格認證。雖然這些短期應對措施有助於穩定生產，但也導致利潤率下降，在某些情況下，也延長了檢驗週期，從而推遲了產品上市。

在此期間，採購團隊和醫療系統調整了採購策略，優先選擇供應鏈多元化且擁有本地生產基礎的供應商，減輕了貿易動態的影響。在整個生態系統中，關稅促使各方對垂直整合方案進行策略性評估，並更重視產品開發中面向供應鏈的彈性設計。重要的是，這些變更也加強了商業部門和監管部門之間的合作，以確保組件替代符合設備安全性和驗證要求。展望未來，那些將關稅風險評估納入早期產品設計並保持靈活供應商網路的機構，將更有能力應對類似的政策變化，並減少營運中斷。

將設備類型、臨床用途、分銷管道、終端用戶治療環境和購買方式與商業化選擇聯繫起來的全面細分洞察

細分市場洞察揭示了臨床需求、技術契合度和商業性管道在設備類型、應用、分銷管道、最終用戶和購買方式等方面的交集。依設備類型分類，市場涵蓋鎮痛輸注幫浦、電刺激設備、磁療設備和射頻消融術設備，並進一步細分為輸注系統（鞘內輸注幫浦和病人自控式止痛幫浦）、電刺激技術（微電流治療電刺激設備、神經肌肉電刺激和經皮神經電刺激）以及射頻消融術方式（雙極電波消融方式和脈衝射頻消融）。這些區分至關重要，因為它們直接關係到手術基礎設施要求、臨床醫生培訓需求和報銷說明，從而為商業化策略提供基礎。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 推出一款配備人工智慧驅動的個人化疼痛通訊協定的穿戴式式TENS設備
  • 數位疼痛管理醫療設備的監管核准環境正在改變。
  • 生物感測器穿戴式設備的整合實現了對疼痛生物標記的即時監測。
  • 非侵入式神經調節頭戴裝置在緩解慢性偏頭痛的興起
  • 擴展遠端醫療平台以支援遠距疼痛治療設備管理
  • 家用冷光照光治療設備作為一種減少鴉片類藥物用量的止痛方法的出現

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 按設備類型分類的疼痛管理設備市場

  • 止痛藥輸注泵
    • 脊髓內泵
    • 患者自控鎮痛泵
  • 電刺激設備
    • 微電流治療電刺激裝置
    • 神經肌肉電刺激
    • 經皮電神經刺激
  • 磁療設備
  • 射頻消融術裝置
    • 雙極射頻消融
    • 單極射頻消融
    • 脈衝射頻消融術

第9章 疼痛管理設備市場：依應用領域分類

  • 癌症疼痛管理
  • 月經疼痛管理
  • 肌肉骨骼疼痛管理
    • 關節炎疼痛
    • 腰痛
  • 神經病變疼痛管理
  • 術後疼痛管理
    • 急性術後疼痛
    • 慢性術後疼痛

第10章 按分銷管道分類的疼痛管理設備市場

  • 離線
  • 線上

第11章 按最終用戶分類的疼痛管理設備市場

  • 居家照護
    • 慢性病居家照護
    • 術後居家照護
  • 醫院和診所
    • 一般診所
    • 疼痛診所
  • 長期照護中心
    • 安寧療護
    • 護理機構

第12章 疼痛管理設備市場：依購買類型分類

  • 非處方藥
  • 處方藥

第13章 疼痛管理設備市場：依地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 按組別分類的疼痛管理設備市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國疼痛管理設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Abbott Laboratories
    • AVACEN, Inc.
    • Avanos Medical, Inc.
    • B. Braun SE
    • BioElectronics Corporation
    • Boston Scientific Corporation
    • CEFALY Technology
    • Enovis Corporation
    • Healthmate International, LLC
    • HMS Medical Systems
    • ICU Medical, Inc.
    • iTENS, LLC
    • Johari Digital
    • Kimberly-Clark Corporation
    • Medtronic PLC
    • Multi Radiance Medical, Inc.
    • NeuroMetrix, Inc.
    • Nevro Corp.
    • OMRON Healthcare, Inc.
    • Oska Wellness
    • Pain Care Labs
    • Pain Management Technologies, Inc.
    • Pfizer, Inc.
    • Sanofi SA
    • Stryker Corporation
    • Ultracare Pro by Zealmax Innovations Pvt. Ltd.
    • Zynex, Inc.
Product Code: MRR-ED54C46E8320

The Pain Management Devices Market is projected to grow by USD 7.32 billion at a CAGR of 9.06% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.65 billion
Estimated Year [2025] USD 3.97 billion
Forecast Year [2032] USD 7.32 billion
CAGR (%) 9.06%

A clear and strategic orientation that frames the evolving clinical, commercial, and regulatory environment shaping modern pain management device strategies

This executive summary opens with an evidence-based orientation to the complex, rapidly evolving field of pain management devices, articulating the purpose of the report and the value it provides to clinical, commercial, and policy stakeholders.

The introduction establishes context by highlighting converging forces that influence product development and adoption, including the shift toward non-opioid therapeutic strategies, the rise of outpatient and home-based care models, and growing integration of digital health capabilities with device platforms. These dynamics are reshaping clinical pathways and decision-making criteria for physicians, hospital administrators, and payers alike. The narrative underscores the need for device makers and service providers to reexamine product portfolios, go-to-market models, and collaborative partnerships in light of clinical preference changes and patient-centric care trends.

Additionally, this section outlines the report's analytical framework and the types of evidence synthesized, clarifying how regulatory considerations, reimbursement pressures, supply chain resilience, and technological convergence inform the insights that follow. By framing key questions around safety, efficacy, usability, and integration, the introduction sets up a pragmatic lens through which readers can interpret subsequent sections and apply findings to product strategy, market entry planning, and investment assessment.

How clinical preference shifts, decentralization of care, digital integration, and evolving regulatory expectations are redefining product and commercial strategies in pain management devices

The landscape of pain management devices is undergoing several transformative shifts that alter clinical workflows, product lifecycles, and commercial priorities.

First, there is a pronounced move toward neuromodulation and minimally invasive interventions as clinicians seek durable, non-pharmacologic modalities to reduce reliance on systemic analgesics. This trend has elevated research into electrical stimulation, radiofrequency techniques, and magnetic therapies that target specific pain pathways while preserving patient mobility and reducing long-term medication exposure. Second, care delivery is decentralizing; devices designed for safe, effective use in home care settings are gaining strategic importance because they support shorter hospital stays and resonate with patient preferences for convenience and privacy. Third, digital augmentation-ranging from remote monitoring and device telemetry to app-based therapy titration and adherence tools-is increasingly a differentiator for both clinical outcomes and payer reimbursement conversations.

Concurrently, regulatory pathways and evidence requirements are evolving to emphasize real-world performance and post-market surveillance, prompting manufacturers to invest in data generation capabilities. Supply chain resilience and component sourcing strategies have become central to product continuity, while strategic partnerships between device companies and service providers accelerate route-to-patient timelines. Together, these shifts require organizations to adopt integrated strategies that align clinical validation, regulatory planning, and commercial execution to remain competitive and relevant.

The 2025 cumulative tariff measures and the resultant supply chain and procurement adjustments that reshaped cost profiles, supplier strategies, and product launch timetables

Cumulative tariff actions implemented in 2025 have introduced amplified cost pressures and procurement complexities across medtech supply chains, creating operational stress for manufacturers and downstream providers.

Tariffs applied to key imported components and subassemblies have increased landed costs for device manufacturers that rely on international sourcing of electronic modules, precision components, and specialized polymers. In response, many organizations undertook near-term cost mitigation measures such as renegotiating supplier contracts, increasing inventory buffers, and accelerating efforts to qualify alternate suppliers from less-impacted jurisdictions. These short-term responses helped stabilize production but introduced margin compression and, in some cases, delayed product launches due to extended validation timelines.

Over the same period, procurement teams and health systems adjusted purchasing strategies, prioritizing suppliers with diversified supply chains or local manufacturing footprints to reduce exposure to trade dynamics. Across the ecosystem, the tariffs catalyzed strategic review of vertical integration options and increased emphasis on design-for-supply resilience during product development. Importantly, these changes also intensified collaboration between commercial and regulatory functions to ensure that component substitutions complied with device safety and validation requirements. Looking ahead, organizations that integrate tariff risk assessment into early-stage product design and maintain flexible supplier networks are positioned to navigate similar policy shifts with less operational disruption.

Comprehensive segmentation insights that connect device types, clinical applications, distribution routes, end-user care settings, and purchase modes to commercialization choices

Segmentation insights illuminate where clinical need, technology fit, and commercial pathways intersect across device type, application, distribution channel, end user, and purchase mode. Based on device type, the market spans analgesic infusion pumps, electrical stimulation devices, magnetic therapy devices, and radiofrequency ablation devices, with further granularity that differentiates intrathecal pumps and patient-controlled analgesia pumps within infusion systems, and microcurrent therapy E-Stim devices, neuromuscular electrical stimulation, and transcutaneous electrical nerve stimulation within electrical stimulation technologies; radiofrequency ablation modalities are further distinguished by bipolar, monopolar, and pulsed RF approaches. These distinctions are material because they align directly with procedural infrastructure requirements, clinician training needs, and reimbursement descriptors, thereby informing commercialization strategy.

Based on application, devices are deployed across cancer pain management, menstrual pain management, musculoskeletal pain management, neuropathic pain management, and post-operative pain management, where musculoskeletal care subdivides into arthritis pain and back pain and post-operative care differentiates between acute post-surgical pain and chronic surgical pain. Clinical utilization patterns across these applications shape product feature priorities, patient selection criteria, and evidence generation plans. Based on distribution channel, end users and purchase pathways vary between offline channels, such as hospitals and clinics, and online channels that serve direct-to-patient models and digital platforms; this split dictates marketing, service, and logistics approaches. Based on end user, the landscape includes home care settings, hospitals and clinics, and long-term care centers, with home care further segmented into chronic illness home care and post-surgery home care, hospitals and clinics differentiating neutral clinics from specialized pain clinics, and long-term care centers including hospices and nursing homes-each setting requires distinct usability, training, and maintenance considerations. Based on mode of purchase, the dichotomy of over-the-counter and prescription-based acquisition defines regulatory pathways, labeling, and clinician involvement in therapy initiation. Together, these segmentation layers provide a practical framework for prioritizing product development, channel strategies, and clinical evidence plans to match each distinct use case and buyer persona.

Distinct regional dynamics and operational priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine market access and commercialization tactics

Regional dynamics influence clinical practice patterns, reimbursement frameworks, and supply chain logistics, creating important implications for product prioritization and market entry approaches. In the Americas, healthcare systems are characterized by a mix of private and public payers, with a strong emphasis on outcomes and evidence-based adoption; this environment rewards devices that deliver demonstrable clinical differentiation and cost-effectiveness while enabling partnerships with integrated delivery networks. In Europe, Middle East & Africa, diverse regulatory regimes and varying reimbursement pathways require tailored regulatory strategies and local clinical validation, and the geopolitical landscape shapes sourcing decisions and deployment timelines for manufacturers of implantable and high-cost therapeutic devices.

Asia-Pacific features heterogeneous markets with rapidly growing demand for outpatient and home-based solutions, rising adoption of digital health tools, and substantial local manufacturing capacity that can support cost-competitive sourcing and faster time-to-market in regional hubs. Across all regions, regional supply chain resilience and the ability to navigate local clinical guidelines and payer expectations remain critical, but the operational priorities differ: the Americas often prioritize rigorous clinical outcomes and integrated care partnerships, Europe, Middle East & Africa call for regulatory navigation and local stakeholder engagement, and Asia-Pacific emphasizes scalability, affordability, and digital-enabled care delivery. Recognizing these contrasts is essential for tailoring market access strategies and regional investment plans.

How established manufacturers, neuromodulation specialists, and software-driven innovators are shaping competitive advantage through clinical evidence, partnerships, and scalable manufacturing

Competitive dynamics in pain management devices reflect a blend of established medical device manufacturers, specialized neuromodulation innovators, and emerging digital therapeutics firms that emphasize software-enabled therapeutic management. Leading organizations tend to combine clinical trial investment with robust post-market evidence collection and strong clinician engagement programs to build trust among prescribers and purchasing groups. At the same time, niche players and start-ups drive rapid innovation in areas such as minimally invasive radiofrequency ablation techniques, wearable electrical stimulation modalities, and connected infusion pump solutions that support remote titration and adherence monitoring.

Manufacturers that pair hardware expertise with software capabilities and data analytics gain a practical advantage in delivering outcome-tracking and reimbursement-ready evidence. Contract manufacturers and component suppliers play a pivotal role in accelerating time-to-market, particularly for companies seeking to optimize manufacturing capacity without large capital expenditures. Strategic partnerships between device firms and digital health service providers are increasingly common, enabling bundled solutions that integrate therapy delivery, remote monitoring, and patient engagement. Investors and acquirers are attentive to organizations demonstrating regulatory maturity, scalable manufacturing, and credible clinical evidence pathways, while service providers that can support post-market surveillance and real-world data capture become indispensable collaborators in commercialization strategies.

Actionable strategic moves for device makers to align design, evidence, supply chain, and commercial models with decentralized care and payer expectations

Industry leaders seeking to maintain or build market leadership should adopt integrated strategies that align product design, clinical evidence generation, and commercial execution to the realities of decentralized care and payer scrutiny. Begin by embedding supply chain risk assessment and component sourcing flexibility into early-stage design decisions so that product availability is less sensitive to policy shifts and tariff volatility. Simultaneously, prioritize modular product architectures and software-first designs that enable rapid iteration, remote updates, and the addition of value-added digital services that support adherence and outcomes tracking.

Invest in pragmatic evidence generation that combines focused randomized studies with real-world data collection to demonstrate clinical benefit across prioritized applications, such as musculoskeletal and post-operative pain, and to support reimbursement discussions with payers. Strengthen commercial relationships by tailoring go-to-market models to the distribution channel and end-user profile, distinguishing strategies for home care, outpatient clinics, and specialized pain centers. Finally, pursue partnerships with contract manufacturers, specialty suppliers, and digital health firms to accelerate time-to-market while preserving capital efficiency. Taken together, these actions help firms reduce time-to-adoption, mitigate operational risk, and secure a defensible position in a market that increasingly values integrated clinical and digital solutions.

A rigorous, multi-source research approach combining expert interviews, clinical and regulatory analysis, and supply chain mapping to ensure validated and actionable insights

The research methodology underpinning this analysis integrates primary qualitative interviews, document and literature synthesis, regulatory and clinical trial review, and supply chain mapping to ensure robust, triangulated insights. Primary inputs include structured interviews with clinicians across specialties that manage pain, procurement leaders within hospitals and integrated delivery networks, product development leaders at device companies, and supply chain and regulatory specialists. These conversations were designed to capture frontline perspectives on usability, clinical acceptance, and procurement criteria.

Secondary investigation incorporated peer-reviewed clinical literature, regulatory filings, patent landscapes, and publicly available clinical trial registries to assess safety profiles, procedural adoption, and evidence maturity; cross-referencing these sources ensured consistency with practitioner-reported trends. Supply chain analysis examined component sourcing, manufacturing footprints, and logistics vulnerabilities to contextualize tariff impacts and procurement responses. Finally, findings were subjected to iterative validation through expert review panels to confirm interpretive accuracy, clarify ambiguous patterns, and refine practical recommendations for stakeholders seeking to align product strategy with evolving clinical and commercial conditions.

Synthesis of strategic imperatives emphasizing agility, evidence integration, and partnership-driven commercialization in the evolving pain management device market

In conclusion, the pain management device landscape is entering a phase characterized by purposeful innovation, decentralization of care, and greater integration of digital capabilities with therapeutic hardware. These forces are driving differentiation around usability, evidence generation, and service-enabled offerings that extend beyond the device itself. Organizations that respond by aligning early-stage product design with supply chain resilience, by integrating data collection into clinical workflows, and by tailoring commercialization strategies to specific clinical applications and end-user settings will be better positioned to capture sustainable value.

Moreover, the interplay of trade policy, reimbursement complexity, and clinician preference means that organizational agility-expressed through flexible supplier relationships, modular product development, and adaptive regulatory strategies-will be a defining characteristic of successful companies. The strategic path forward emphasizes partnerships, digital integration, and pragmatic evidence generation as core competencies. Firms that cultivate these capabilities can better meet clinician needs, improve patient outcomes, and create compelling value propositions for payers and health systems alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of wearable TENS devices with AI-driven personalized pain protocols
  • 5.2. Regulatory approval landscape evolving for digital pain management health devices
  • 5.3. Integration of biosensor wearables enabling real-time monitoring of pain biomarkers
  • 5.4. Rise of non-invasive neuromodulation headsets for chronic migraine relief therapies
  • 5.5. Expansion of telehealth platforms supporting remote pain therapy device management
  • 5.6. Emergence of at-home cold laser therapy devices as opioid-sparing pain solutions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pain Management Devices Market, by Device Type

  • 8.1. Analgesic Infusion Pumps
    • 8.1.1. Intrathecal Pumps
    • 8.1.2. Patient-Controlled Analgesia Pumps
  • 8.2. Electrical Stimulation Devices
    • 8.2.1. Microcurrent Therapy E-Stim Devices
    • 8.2.2. Neuromuscular Electrical Stimulation
    • 8.2.3. Transcutaneous Electrical Nerve Stimulation
  • 8.3. Magnetic Therapy Devices
  • 8.4. Radiofrequency Ablation Devices
    • 8.4.1. Bipolar RF Ablation
    • 8.4.2. Monopolar RF Ablation
    • 8.4.3. Pulsed RF Ablation

9. Pain Management Devices Market, by Application

  • 9.1. Cancer Pain Management
  • 9.2. Menstrual Pain Management
  • 9.3. Musculoskeletal Pain Management
    • 9.3.1. Arthritis Pain
    • 9.3.2. Back Pain
  • 9.4. Neuropathic Pain Management
  • 9.5. Post-Operative Pain Management
    • 9.5.1. Acute Post-Surgical Pain
    • 9.5.2. Chronic Surgical Pain

10. Pain Management Devices Market, by Distribution Channel

  • 10.1. Offline
  • 10.2. Online

11. Pain Management Devices Market, by End User

  • 11.1. Home Care Settings
    • 11.1.1. Chronic Illness Home Care
    • 11.1.2. Post-Surgery Home Care
  • 11.2. Hospitals And Clinics
    • 11.2.1. Neutral Clinics
    • 11.2.2. Pain Clinics
  • 11.3. Long-Term Care Centers
    • 11.3.1. Hospices
    • 11.3.2. Nursing Homes

12. Pain Management Devices Market, by Mode of Purchase

  • 12.1. Over-the-counter
  • 12.2. Prescription-based

13. Pain Management Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pain Management Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pain Management Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. AVACEN, Inc.
    • 16.3.3. Avanos Medical, Inc.
    • 16.3.4. B. Braun SE
    • 16.3.5. BioElectronics Corporation
    • 16.3.6. Boston Scientific Corporation
    • 16.3.7. CEFALY Technology
    • 16.3.8. Enovis Corporation
    • 16.3.9. Healthmate International, LLC
    • 16.3.10. HMS Medical Systems
    • 16.3.11. ICU Medical, Inc.
    • 16.3.12. iTENS, LLC
    • 16.3.13. Johari Digital
    • 16.3.14. Kimberly-Clark Corporation
    • 16.3.15. Medtronic PLC
    • 16.3.16. Multi Radiance Medical, Inc.
    • 16.3.17. NeuroMetrix, Inc.
    • 16.3.18. Nevro Corp.
    • 16.3.19. OMRON Healthcare, Inc.
    • 16.3.20. Oska Wellness
    • 16.3.21. Pain Care Labs
    • 16.3.22. Pain Management Technologies, Inc.
    • 16.3.23. Pfizer, Inc.
    • 16.3.24. Sanofi S.A.
    • 16.3.25. Stryker Corporation
    • 16.3.26. Ultracare Pro by Zealmax Innovations Pvt. Ltd.
    • 16.3.27. Zynex, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. PAIN MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. PAIN MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PAIN MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2025-2032 (USD MILLION)

TABLE 29